Form 4: Guardant Health Director Acquires Shares

Guardant Health Director Steve Krognes acquired 155 shares of common stock through the vesting of restricted stock units.

Summary

• Steve Krognes, a Director at Guardant Health, Inc., acquired 155 shares of common stock on June 30, 2026.
• The acquisition was a result of the vesting of restricted stock units (RSUs) granted on August 9, 2022.
• This transaction is reported under SEC Form 4, indicating a change in beneficial ownership.
• The shares were acquired at a price of $0, as they represent vested RSUs.
• Following the transaction, Krognes beneficially owns 14,580 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine insider transaction (vesting of RSUs) without new financial information or strategic updates.

Positives

• Director Krognes's acquisition of shares through RSU vesting indicates continued alignment with the company's performance and long-term value.
• The vesting of RSUs suggests that performance or service conditions associated with the award have been met.

Future Outlook

The filing does not contain forward-looking statements or guidance. It reports a completed transaction.

Industry Context

StockSavvy.ai notes that insider transactions, such as the vesting of restricted stock units by directors, are common in the biotechnology and healthcare sectors, reflecting long-term incentive alignment. Guardant Health operates in the precision oncology market, where such equity-based compensation is standard practice.

Stakeholder Impact

• Shareholders: The transaction itself does not directly impact share price but reflects ongoing compensation practices and insider ownership.
• Employees: The vesting of RSUs for directors is part of the broader compensation structure, which can influence employee morale and retention.
• Management: Demonstrates continued commitment and alignment of director compensation with company performance.

Key Dates

Keywords

Guardant Health, GH, Form 4, SEC Filing, Insider Transaction, Restricted Stock Units, RSU Vesting, Director, Beneficial Ownership